Europe (WHO region) vs Uzbekistan: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Europe (WHO region)
89.0%
in 2025
Uzbekistan
99.0%
in 2025
Europe (WHO region) rank
2nd
Uzbekistan rank
1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Europe (WHO region)
- Uzbekistan
How they compare
Uzbekistan currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Uzbekistan's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 3 times across 5 shared years of data; in 2021 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 2nd and Uzbekistan ranks 1st of 11 groups.
Europe (WHO region) has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Europe (WHO region) or Uzbekistan?
- Uzbekistan, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Europe (WHO region) and Uzbekistan?
- 10.0%, with Uzbekistan ahead.
- How many years of comparable data are there for Europe (WHO region) and Uzbekistan?
- 5 years are reported by both, from 2021 to 2025.
- How do Europe (WHO region) and Uzbekistan rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Europe (WHO region) ranks 2nd and Uzbekistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.